HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Hologic Acquires Gynesonics to Strengthen Existing Gynecological Surgical Business

By HospiMedica International staff writers
Posted on 22 Oct 2024
Print article
Image: The Sonata System combines real-time intrauterine ultrasound guidance with targeted radiofrequency ablation in an incisionless procedure (Photo courtesy of Gynesonics)
Image: The Sonata System combines real-time intrauterine ultrasound guidance with targeted radiofrequency ablation in an incisionless procedure (Photo courtesy of Gynesonics)

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Gynesonics (Redwood City, CA, USA) for approximately USD 350 million, subject to working capital and other customary closing adjustments.

Gynesonics is a privately held medical device company dedicated to developing minimally invasive solutions for women’s health. The company pioneered and launched the Sonata System, which is the first FDA-cleared medical device designed for diagnostic intrauterine imaging and transcervical treatment of specific symptomatic uterine fibroids, including those linked to heavy menstrual bleeding. The Sonata System is unique as the world’s first and only intrauterine fibroid ablation system that combines the safety of ultrasound guidance with the established benefits of targeted radiofrequency energy, all within a single transcervical, incision-less procedure. The transcervical delivery method avoids entering the peritoneal cavity and does not necessitate general anesthesia. The Sonata System is capable of treating most types of fibroids, including submucous, intramural, transmural, and subserous fibroids, providing a groundbreaking alternative to traditional hysterectomy and myomectomy. The acquisition of Gynesonics strengthens Hologic’s innovative portfolio of medical technologies that effectively detect, diagnose, and treat women's health conditions.

“Gynesonics’ Sonata System complements our offering and will give GYN surgeons across the globe an expanded range of options to treat women suffering from heavy periods and fibroids,” said Brandon Schnittker, Division President of Surgical Solutions at Hologic. “This acquisition furthers our commitment to providing women with minimally invasive treatment options. We are enthusiastic about the future as we work to expand access to and drive innovation for treatments that enhance women’s quality of life.”

Related Links:
Hologic
Gynesonics

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Pressure Monitoring Mattress
Entrix NX
New
Mobile Patient Lift
Golvo 9000

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more